Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.49B 520M 454M 429M 389M 728M 49.9B 734M 5.13B 1.98B 25.34B 1.95B 1.91B 81.26B P/E 2026 *
7.67x
P/E 2027 * 6.81x
Enterprise Value 3.49B 520M 454M 429M 389M 728M 49.9B 734M 5.13B 1.98B 25.34B 1.95B 1.91B 81.26B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.46x
Free-Float
45.7%
Yield 2026 *
5.88%
Yield 2027 * 6.61%
28/08 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
28/08 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day+1.19%
1 week+2.41%
Current month+13.33%
1 month+7.59%
3 months-9.57%
6 months-24.78%
Current year-27.04%
1 week 0.31
Extreme 0.308
0.34
1 month 0.3
Extreme 0.3
0.34
Current year 0.3
Extreme 0.3
0.5
1 year 0.3
Extreme 0.3
0.55
3 years 0.3
Extreme 0.3
0.8
5 years 0.3
Extreme 0.3
1.02
10 years 0.3
Extreme 0.3
1.3
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 43 28/11/2025
Director TitleAgeSince
Director/Board Member 69 12/06/2018
Director/Board Member 66 06/02/2026
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+2.41% - - 518M
+0.20%-0.06%-13.85%-4.94% 13.48B
-0.69%-4.89%-33.89%-56.82% 4.76B
-0.24%-1.86%-4.27%-5.45% 4.38B
-0.13%-4.47%-10.50%-32.20% 3.78B
-0.90%-1.89%-1.21%-3.17% 3.51B
+0.09%-4.24%-24.70%-2.15% 3.39B
-0.43%-4.40%-13.44%-2.04% 3.11B
+0.68%-0.88%-22.17%-17.68% 2.29B
+0.58%-4.95%-29.94%-22.26% 1.61B
Average +0.03%-1.15%-17.11%-16.30% 4.48B
Weighted average by Cap. -0.08%-0.63%-15.75%-14.48%

Financials

2026 *2027 *
Net sales 6.98B 1.04B 908M 860M 778M 1.46B 99.9B 1.47B 10.26B 3.96B 50.73B 3.91B 3.82B 163B 7.56B 1.13B 984M 931M 843M 1.58B 108B 1.59B 11.12B 4.29B 54.96B 4.24B 4.14B 176B
Net income 454M 67.78M 59.13M 55.95M 50.66M 94.83M 6.5B 95.64M 668M 258M 3.3B 255M 249M 10.59B 514M 76.58M 66.81M 63.22M 57.24M 107M 7.35B 108M 755M 291M 3.73B 288M 281M 11.96B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,801
Date Price Change
16/09/26 EUR 0.3320 -1.19%
15/09/26 EUR 0.3360 +1.20%
14/09/26 EUR 0.3320 +5.73%
11/09/26 EUR 0.3140 +1.95%
10/09/26 EUR 0.3080 -8.33%
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.723CNY
Average target price
4.601CNY
Spread / Average Target
+68.95%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!